VTI
vs
S
S&P/ASX 300
VTI
Over the past 12 months, VTI has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +8% growth.
Stocks Performance
VTI vs S&P/ASX 300
Performance Gap
VTI vs S&P/ASX 300
Performance By Year
VTI vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Visioneering Technologies Inc
Glance View
Visioneering Technologies, Inc. is an eye care company, which engages in the design, manufacture, sale, and distribution of contact lenses. The company is headquartered in Alpharetta, Georgia. The company went IPO on 2017-03-28. The firm is primarily engaged in the design, manufacture, sale and distribution of a contact lens, the NaturalVue Multifocal 1 Day (NaturalVue MF) contact lens. The firm operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. Its flagship product is the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens for adults with Presbyopia and children with Myopia. The firm sells its contact lenses in the United States, Europe, Australia, New Zealand, Hong Kong, Singapore, Canada and Malaysia. The firm manages the warehousing and distribution of its products through a contract with a third-party logistics provider (the 3PL).
